http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-079268-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
filingDate 2010-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b759896ddfde2a6a37d764b800091038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eae7f8753b3d67c16b61b85fbf0b5d7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b12de48513452f436b4d6273b936c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb63e32b4f7cc62ca7d8f599b80d6fc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dec82f6862ed4684a1ba93458cc0d2f
publicationDate 2012-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-079268-A1
titleOfInvention DERIVATIVES OF AZABICICLO (3.2.0) HEPT-3-ILO, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract Medication that interacts with the central histaminergic systems. Claim 1: Compounds of formula (1) wherein ALK represents an alkylene chain, W represents a group -N (R ') C (= O) R or -C (= O) N (R') R in which R and R 'represent, independently of each other, a hydrogen atom or a linear or branched C1-6 alkyl group optionally substituted with one or more groups chosen from halogen, hydroxy and alkoxy, it being understood that the term alkylene designates a bivalent radical , linear or branched, containing 2 to 6 carbon atoms, the term "alkoxy" means an alkyl-oxy group whose alkyl chain, linear or branched, contains 1 to 6 carbon atoms, their enantiomers and diastereoisomers, as well as their salts of addition to an acid or a pharmaceutically acceptable base.
priorityDate 2009-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 32.